[go: up one dir, main page]

NO903291L - PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES. - Google Patents

PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.

Info

Publication number
NO903291L
NO903291L NO90903291A NO903291A NO903291L NO 903291 L NO903291 L NO 903291L NO 90903291 A NO90903291 A NO 90903291A NO 903291 A NO903291 A NO 903291A NO 903291 L NO903291 L NO 903291L
Authority
NO
Norway
Prior art keywords
aminooligo
hydroxyde
inhibitive
derivatives
pure
Prior art date
Application number
NO90903291A
Other languages
Norwegian (no)
Other versions
NO903291D0 (en
Inventor
Heinz-Werner Kleemann
Hansjoerg Urbach
Adalbert Wagner
Dieter Ruppert
Wolfgang Linz
Werner Kramer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3924506A external-priority patent/DE3924506A1/en
Priority claimed from DE19893932817 external-priority patent/DE3932817A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO903291D0 publication Critical patent/NO903291D0/en
Publication of NO903291L publication Critical patent/NO903291L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)

Abstract

Forbindelser med formel I. der. A, R • R, Rog n er definert som angitt 1 beskrivelsen, fremgangsmåte for fremstilling derav, anvendelse som legemiddel og farmasøytisk middel inneholdende disse er beskrevet.Compounds of formula I. there. A, R • R, Rog n are defined as indicated in the description, process for their preparation, use as a medicament and pharmaceutical agent containing these are described.

NO90903291A 1989-07-25 1990-07-24 PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES. NO903291L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3924506A DE3924506A1 (en) 1989-07-25 1989-07-25 New poly:hydroxy:amide derivs.
DE19893932817 DE3932817A1 (en) 1989-09-30 1989-09-30 New poly:hydroxy:amide derivs.

Publications (2)

Publication Number Publication Date
NO903291D0 NO903291D0 (en) 1990-07-24
NO903291L true NO903291L (en) 1991-01-28

Family

ID=25883333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903291A NO903291L (en) 1989-07-25 1990-07-24 PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.

Country Status (20)

Country Link
EP (1) EP0410278B1 (en)
JP (1) JPH0366652A (en)
KR (1) KR910002776A (en)
CN (1) CN1049164A (en)
AT (1) ATE100463T1 (en)
AU (1) AU639246B2 (en)
CA (1) CA2021822A1 (en)
CS (1) CS368890A3 (en)
DE (1) DE59004292D1 (en)
DK (1) DK0410278T3 (en)
ES (1) ES2062214T3 (en)
FI (1) FI903701A7 (en)
HU (1) HU205140B (en)
IE (1) IE902686A1 (en)
IL (1) IL95166A0 (en)
MA (1) MA21913A1 (en)
NO (1) NO903291L (en)
NZ (1) NZ234608A (en)
PL (1) PL286188A1 (en)
PT (1) PT94798A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209870B (en) * 1990-01-18 1993-07-21 Pfizer
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
EP0546115A1 (en) * 1990-08-24 1993-06-16 The Upjohn Company Peptides containing amino-polyols as transition-state mimics
EP0483403A1 (en) * 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
AU4686401A (en) * 2000-04-10 2001-10-23 Yuichi Ishida Hypotensors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34086A (en) * 1985-01-23 1986-07-24 Abbott Lab PEPTIDYLAMINODIOLS
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II

Also Published As

Publication number Publication date
EP0410278A1 (en) 1991-01-30
CN1049164A (en) 1991-02-13
HUT55033A (en) 1991-04-29
NO903291D0 (en) 1990-07-24
EP0410278B1 (en) 1994-01-19
PL286188A1 (en) 1991-04-22
IL95166A0 (en) 1991-06-10
HU205140B (en) 1992-03-30
HU904582D0 (en) 1990-12-28
NZ234608A (en) 1991-12-23
DE59004292D1 (en) 1994-03-03
FI903701A0 (en) 1990-07-23
AU639246B2 (en) 1993-07-22
JPH0366652A (en) 1991-03-22
ATE100463T1 (en) 1994-02-15
IE902686A1 (en) 1991-02-27
MA21913A1 (en) 1991-04-01
AU5971990A (en) 1991-01-31
DK0410278T3 (en) 1994-05-24
KR910002776A (en) 1991-02-26
CA2021822A1 (en) 1991-01-26
CS368890A3 (en) 1992-02-19
FI903701A7 (en) 1991-01-26
PT94798A (en) 1991-03-20
ES2062214T3 (en) 1994-12-16

Similar Documents

Publication Publication Date Title
SE9904505D0 (en) Novel compounds
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
DK0530087T3 (en) New Naphthylethylurea and Naphthylethylthiourea Compounds, Methods of Preparation and Pharmaceutical Agents Containing Them
EE200000320A (en) Novel compounds
SE9704544D0 (en) Novel compounds
FI903215A7 (en) Heteroarylamino- and heteroaryloxypyridineamines and related compounds, process for their preparation and their use as medicaments
DK0506539T3 (en) heterocyclic alkylamides, processes for their preparation and pharmaceutical agents containing them
HU903094D0 (en) Process for the preparation of antiphlogistic amino-phenol derivatives
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
ZA953701B (en) New atagonist compounds
NO178768C (en) 11-aryl-4-oestrenes and contraceptives containing them
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
FI934298A0 (en) CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, DESS FRAMSTAELLNING OCH DESS ANVAENDNING
PT722319E (en) ANTRACICLINONE DERIVATIVES AND THEIR USE IN AMYLOIDOSE TREATMENT
DK0486386T3 (en) New N-benzoylproline derivatives, processes for their preparation and pharmaceutical agents containing them
ES2020171T3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOLE ETHERS WITH 2-ALIPHATIC HYDROXIACIDES.
SE9400447D0 (en) New compounds
MY114282A (en) Anthracycline derivatives
NO903291L (en) PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.
FI905191A7 (en) Benzocykloalylaminopyridinamines and related compounds, procedure and intermediate products for their preparation and use as medicines
DE69132578D1 (en) Cephem derivatives
FI940031L (en) New 2-cyano-3-hydroxypropenamide derivatives, a process for their preparation, their use as medicaments and pharmaceutical compositions containing them
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
ES2065855B1 (en) PROCEDURE FOR THE PREPARATION OF NEW DEOXIAZAPHOSPHOLIPIDIC DERIVATIVES WITH INHIBITING ACTION OF THE PHOSFOLIPASE A2, NEW DERIVATIVES DEOXIAZAPHOSPHOLIPIDICES OBTAINED AND USE OF THEM.
DK256689D0 (en) 1,2-DITHIOL-3-THION-S-OXIDE COMPOUNDS FOR USE AS MEDICINAL PRODUCTS